Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$2.81 - $4.45 $44 - $71
16 Added 0.07%
21,601 $91,000
Q3 2022

Nov 10, 2022

SELL
$2.82 - $7.52 $26,524 - $70,733
-9,406 Reduced 30.35%
21,585 $61,000
Q2 2022

Aug 12, 2022

BUY
$2.73 - $5.61 $35,730 - $73,423
13,088 Added 73.11%
30,991 $125,000
Q4 2021

Feb 09, 2022

BUY
$4.47 - $5.56 $80,026 - $99,540
17,903 New
17,903 $81,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $502M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.